ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

119
Analysis
Health Care • South Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
bearish•Quantitative Analysis
•07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
447 Views
Share
bearish•Quantitative Analysis
•01 Jun 2020 05:42

Asia Short Interest Weekly - HK Financials and Property, Japan Real Estate, Korea Tech, Taiwan Semis

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
407 Views
Share
bullish•Celltrion Healthcare
•27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
437 Views
Share
bullish•Celltrion Healthcare
•26 May 2020 17:37

A Block Deal Placement (348 Billion Won) Of Celltrion Healthcare by One Equity Partners

After the market close today, it was announced that One Equity Partners private equity firm will sell 348 billion won worth of Celltrion Healthcare...

Logo
498 Views
Share
bullish•Quantitative Analysis
•15 Apr 2020 05:39

Biotech & Pharma Moving Up As Short Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 10 April 2020, the...

Logo
502 Views
Share
x